150
Participants
Start Date
February 17, 2023
Primary Completion Date
February 28, 2025
Study Completion Date
December 31, 2025
Dose of 0.5% Ropivacaine
Dose varied by 5mL of 0.5% Ropivacaine
RECRUITING
Virginia Mason Medical Center, Seattle
Lead Sponsor
Benaroya Research Institute
OTHER